Intervention

MT-3995 Low

ClinicalTrials.gov intervention label

Clinical trials4
Recruiting0
Common conditions1
Lead sponsors shown1
Advertisement

Clinical trials

4 shown
An Extended Treatment Study of MT-3995 in Patients With Diabetic NephropathyNCT02676401 · 2016-02-01
COMPLETED
Efficacy and Safety of MT-3995 in Patients With Diabetic NephropathyNCT02517320 · 2015-07-01
COMPLETED
A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFRNCT01756716 · 2012-12-01
COMPLETED
A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With AlbuminuriaNCT01756703 · 2012-11-01
COMPLETED

Trial status mix

COMPLETED4

Phase mix

PHASE24

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.